Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 203 (RN7SKP203) is a **pseudogene**—a genomic DNA sequence similar to the functional *RN7SK* gene but presumed to lack biological activity due to genetic mutations or loss of essential regulatory elements[3][7][8]. The functional *RN7SK* gene encodes a small nuclear RNA (7SK RNA), which is a central scaffold for the **7SK small nuclear ribonucleoprotein (snRNP)** complex involved in negative regulation of transcription elongation through RNA polymerase II, impacting transcriptional control in metazoans[1][2][5]. However, pseudogenes like RN7SKP203 typically do **not produce functional RNA products and are not considered therapeutic targets** such as receptors, enzymes, or transporters[3][7][8]. There is no evidence that RN7SKP203 has a direct role in biological functions, disease pathology, or interaction with drugs. Its presence in some transcriptomic datasets may reflect transcriptional noise or non-functional expression rather than a meaningful biological or therapeutic role[8]. **Critical notes:** - Pseudogenes are distinct from their functional counterparts: although related to RN7SK, RN7SKP203 is cataloged as a pseudogene and **should not be treated as a canonical drug target**[3][7][8]. - Searching for information or considering it as a therapeutic target may be an error; the actual target molecule in research or therapy is its functional parent, RN7SK or 7SK RNA[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 203 (RN7SKP203).